Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide-Reference-Cited by-同舟云学术

Risk of Death in Heart Disease is Associated With Elevated Urinary Globotriaosylceramide

Published:2014-01-27 Issue:1 Volume:3 Page:
ISSN:2047-9980
Container-title:Journal of the American Heart Association
language:en
Short-container-title:JAHA

Author:

Schiffmann Raphael¹,Forni Sabrina¹,Swift Caren¹,Brignol Nastry²,Wu Xiaoyang²,Lockhart David J.²,Blankenship Derek³,Wang Xuan³,Grayburn Paul A.⁴,Taylor Matthew R. G.⁵,Lowes Brian D.⁶,Fuller Maria⁷,Benjamin Elfrida R.²,Sweetman Lawrence¹

Affiliation:

1. Institute of Metabolic Disease, Baylor Research Institute, Dallas, TX

2. Amicus Therapeutics, Cranbury, NJ

3. Department of Biostatistics, Baylor Institute for Immunology Research, Dallas, TX

4. Division of Cardiology, Baylor University Medical Center, Dallas, TX

5. Adult Medical Genetics Program, Department of Medicine, University of Colorado, Denver, CO

6. University of Nebraska Medical Center, Omaha, NE

7. Genetics and Molecular Pathology, SA Pathology at Women's and Children's Hospital, North Adelaide, South Australia, Australia

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Cardiology and Cardiovascular Medicine